Novamune inj. susp. (conc.) s.c. amp.

Country: Բելգիա

language: անգլերեն

source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

active_ingredient:

Infectious Bursal Disease Virus (live, attenuated)

MAH:

Ceva Santé Animale SA-NV

ATC_code:

QI01AD09

INN:

Avian Infectious Bronchitis Virus, Live, Attenuated

pharmaceutical_form:

Concentrate for suspension for injection

composition:

Avian Infectious Bronchitis Virus, Live, Attenuated

administration_route:

Subcutaneous use

therapeutic_group:

poultry

therapeutic_area:

Avian Infectious Bursal Disease Virus (Gumboro Disease)

leaflet_short:

CTI code: 534062-04 - Pack size: 500 doses (2 (2) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 534062-03 - Pack size: 5 x 2000 doses - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 534062-02 - Pack size: 5 x 1000 doses - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 534062-01 - Pack size: 5 x 500 doses - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 534062-08 - Pack size: 2000 doses - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 534062-07 - Pack size: 1000 doses (5 (5) - Commercialisation status: YES - Delivery mode: Medical prescription; CTI code: 534062-06 - Pack size: 1000 doses (2 (2) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 534062-05 - Pack size: 500 doses (5 (5) - Commercialisation status: NO - Delivery mode: Medical prescription

authorization_status:

Commercialised: Yes

authorization_date:

2018-09-11